Key Details
Price
$11.60Annual ROE
-9.51%Beta
1.48Events Calendar
Next earnings date:
Feb 20, 2025Recent quarterly earnings:
Oct 30, 2024Recent annual earnings:
Feb 20, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Teladoc Health, Inc.'s telehealth model struggles with low utilization despite its potential, leading to consistent operating losses and a declining average revenue per member. New CEO Chuck Divita aims to revitalize Teladoc by enhancing value propositions, cutting costs, and potentially selling or restructuring the Better Help segment. Teladoc's survival hinges on cost-cutting, maintaining integrated care clients, and resolving Better Help's profitability issues, with a cautious outlook for 2025.
TDOC's upgraded Virtual Sitter uses AI to prevent patient falls, boost staff efficiency and enhance care delivery, thus addressing major challenges in hospitals and health systems.
New artificial intelligence (AI) capabilities help hospitals and health systems deliver safer and more efficient care New artificial intelligence (AI) capabilities help hospitals and health systems deliver safer and more efficient care
PURCHASE, NY, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the 36th Annual Piper Sandler Healthcare Conference in New York on Tuesday, December 3, 2024, at 12:30 p.m. ET. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations/.
Spoiler: The news isn't pretty.
This telehealth leader has a lot of work to do.
Hint: You won't find it on the top or bottom lines.
Teladoc Health, Inc. (NYSE:TDOC ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Michael Minchak - Head of Investor Relations Chuck Divita - Chief Executive Officer Mala Murthy - Chief Financial Officer Conference Call Participants Stephanie Davis - Barclays Lisa Gill - JPMorgan Jessica Tassan - Piper Sandler Michael Cherny - Leerink Partners Sean Dodge - RBC Capital Markets Sarah James - Cantor Fitzgerald Jailendra Singh - Truist Securities Richard Close - Cannacord Glen Santangelo - Jefferies Charles Rhyee - TD Cowen Allen Lutz - Bank of America Sameer Patel - Evercore ISI Operator Hello, and welcome to the Teladoc Health Third Quarter 2024 Call. My name is Alex, and I'll be coordinating the call today.
Although the revenue and EPS for Teladoc (TDOC) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
FAQ
- What is the primary business of Teladoc Health?
- What is the ticker symbol for Teladoc Health?
- Does Teladoc Health pay dividends?
- What sector is Teladoc Health in?
- What industry is Teladoc Health in?
- What country is Teladoc Health based in?
- When did Teladoc Health go public?
- Is Teladoc Health in the S&P 500?
- Is Teladoc Health in the NASDAQ 100?
- Is Teladoc Health in the Dow Jones?
- When was Teladoc Health's last earnings report?
- When does Teladoc Health report earnings?
- Should I buy Teladoc Health stock now?